Phathom Pharmaceuticals, Inc.

Phathom Pharmaceuticals is a biopharmaceutical company committed to transforming the treatment landscape and improving the lives of patients suffering from acid-related gastrointestinal (GI) disorders. The company has licensed exclusive rights in the United States, Europe, and Canada to a potassium-competitive acid blocker (PCAB) for the treatment of certain GI disorders.

Phathom Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing new treatments for gastrointestinal (GI) diseases. It has licensed exclusive rights in the United States, Europe, and Canada to a potassium-competitive acid blocker (PCAB), which the company has been developing for the treatment of certain GI disorders.

• VOQUEZNA®

  A product offered by Phathom, with U.S. Prescribing Information available.

• VOQUEZNA® Triple Pak® & Dual Pak®

  Products offered by Phathom, with U.S. Prescribing Information available.

1. 1Phathom Pharmaceuticals – Leading the way to innovative treatments for gastrointestinal diseasesphathompharma.com
2. 2About Us - Phathom Pharmaceuticalsphathompharma.com
3. 3Our Products – Phathom Pharmaceuticalsphathompharma.com
4. 4Phathom Pharmaceuticals, Inc. (United States)wikidata.org